Research Article

Management of early-stage Kienböck disease (stages 1–3a) with vascularized bone grafting

Volume: 9 Number: 1 January 5, 2026
TR EN

Management of early-stage Kienböck disease (stages 1–3a) with vascularized bone grafting

Abstract

Aims: Kienböck’s disease is characterized by avascular necrosis of the lunate, with its etiology still debated. Vascularized bone grafting (VBG) has emerged as a surgical option for early-stage disease to improve vascularity and preserve carpal function. This study aimed to evaluate clinical and functional outcomes of stage 1–3A Kienböck’s disease treated with a pedicled VBG based on the 4th and 5th extensor compartment arteries (ECAs). Methods: This retrospective cohort included 22 patients (7 stage 1, 9 stage 2, 6 stage 3A) treated between 2017 and 2023. Surgical technique involved harvesting a corticospongious graft from the distal radius, transferred on the 4+5 ECA pedicle into the lunate defect. Postoperatively, a short-arm splint was applied for 4–6 weeks, followed by physiotherapy. Outcomes were assessed preoperatively and at 12 months: wrist flexion–extension arc, ulnar–radial deviation, grip strength, Visual Analog Scale (VAS, 0–100), and QuickDASH. Paired comparisons were performed with the paired T-test or Wilcoxon signed-rank test; comparisons among disease stages (stage 1, stage 2, and stage 3A) were performed using the Kruskal–Wallis test. Results: At one year, patients demonstrated significant improvements: flexion–extension arc (90.05°→128.00°, p<.001), ulnar radial deviation (32.05°→37.60°, p<.001), grip strength (23.59→37.59 kg, p<.001), VAS (65.23→22.45, p<.001), and QuickDASH (55.60→19.60, p<.001). Subgroup analysis confirmed significant within-stage improvements (p<.001for all parameters). Interstage comparisons revealed no statistically significant differences in outcomes (all p>.05). Superficial wound infection occurred in three patients (13.6%) and resolved with oral antibiotics. No donor-site morbidity, neurovascular complications, or graft failures were observed. Conclusion: The 4+5 ECA-based vascularized bone graft appears to be a safe and effective option for early-stage Kienböck’s disease, providing meaningful short-term clinical and functional improvement with a low complication rate. However, due to the retrospective design and the absence of standardized radiological outcome measures, the present findings should be interpreted as short- to mid-term clinical results rather than evidence of radiological revascularization or prevention of disease progression. Further prospective studies with larger cohorts are warranted to confirm long-term efficacy and to compare this technique with alternative surgical strategies.

Keywords

References

  1. Nasr LA, Koay J. Kienbock Disease. In: StatPearls. Treasure Island (FL): StatPearls 2023.
  2. Chojnowski K, Opiełka M, Piotrowicz M, et al. Recent advances in assessment and treatment in Kienböck's disease. J Clin Med. 2022;11 (3):664. doi:10.3390/jcm11030664
  3. Schiltenwolf M, Martini AK, Mau HC, Eversheim S, Brocai DR, Jensen CH. Further investigations of the intraosseous pressure characteristics in necrotic lunates (Kienböck's disease). J Hand Surg Am. 1996;21(5):754-758. doi:10.1016/S0363-5023(96)80187-0
  4. Low SC, Bain GI, Findlay DM, Eng K, Perilli E. External and internal bone micro-architecture in normal and Kienböck's lunates: a whole-bone micro-computed tomography study. J Orthop Res. 2014;32(6):826-833. doi:10.1002/jor.22611
  5. van Leeuwen WF, Janssen SJ, ter Meulen DP, Ring D. What is the radiographic prevalence of incidental Kienböck disease?. Clin Orthop Relat Res. 2016;474(3):808-813. doi:10.1007/s11999-015-4541-1
  6. Mennen U, Sithebe H. The incidence of asymptomatic Kienböck's disease. J Hand Surg Eur Vol. 2009;34(3):348-350. doi:10.1177/1753193408098481
  7. Kazmers NH, Yu Z, Barker T, Abraham T, Romero R, Jurynec MJ. Evaluation for Kienböck disease familial clustering: a population-based cohort study. J Hand Surg Am. 2020;45(1):1-8.e1. doi:10.1016/j.jhsa.2019. 10.005
  8. Daly CA, Graf AR. Kienböck disease: clinical presentation, epidemiology, and historical perspective. Hand Clin. 2022;38(4):385-392. doi:10.1016/j.hcl.2022.03.002

Details

Primary Language

English

Subjects

Orthopaedics

Journal Section

Research Article

Publication Date

January 5, 2026

Submission Date

November 21, 2025

Acceptance Date

December 31, 2025

Published in Issue

Year 2026 Volume: 9 Number: 1

APA
Güneş, Z., & Erdoğan, E. (2026). Management of early-stage Kienböck disease (stages 1–3a) with vascularized bone grafting. Journal of Health Sciences and Medicine, 9(1), 228-233. https://doi.org/10.32322/jhsm.1827790
AMA
1.Güneş Z, Erdoğan E. Management of early-stage Kienböck disease (stages 1–3a) with vascularized bone grafting. J Health Sci Med / JHSM. 2026;9(1):228-233. doi:10.32322/jhsm.1827790
Chicago
Güneş, Zafer, and Eralp Erdoğan. 2026. “Management of Early-Stage Kienböck Disease (stages 1–3a) With Vascularized Bone Grafting”. Journal of Health Sciences and Medicine 9 (1): 228-33. https://doi.org/10.32322/jhsm.1827790.
EndNote
Güneş Z, Erdoğan E (January 1, 2026) Management of early-stage Kienböck disease (stages 1–3a) with vascularized bone grafting. Journal of Health Sciences and Medicine 9 1 228–233.
IEEE
[1]Z. Güneş and E. Erdoğan, “Management of early-stage Kienböck disease (stages 1–3a) with vascularized bone grafting”, J Health Sci Med / JHSM, vol. 9, no. 1, pp. 228–233, Jan. 2026, doi: 10.32322/jhsm.1827790.
ISNAD
Güneş, Zafer - Erdoğan, Eralp. “Management of Early-Stage Kienböck Disease (stages 1–3a) With Vascularized Bone Grafting”. Journal of Health Sciences and Medicine 9/1 (January 1, 2026): 228-233. https://doi.org/10.32322/jhsm.1827790.
JAMA
1.Güneş Z, Erdoğan E. Management of early-stage Kienböck disease (stages 1–3a) with vascularized bone grafting. J Health Sci Med / JHSM. 2026;9:228–233.
MLA
Güneş, Zafer, and Eralp Erdoğan. “Management of Early-Stage Kienböck Disease (stages 1–3a) With Vascularized Bone Grafting”. Journal of Health Sciences and Medicine, vol. 9, no. 1, Jan. 2026, pp. 228-33, doi:10.32322/jhsm.1827790.
Vancouver
1.Zafer Güneş, Eralp Erdoğan. Management of early-stage Kienböck disease (stages 1–3a) with vascularized bone grafting. J Health Sci Med / JHSM. 2026 Jan. 1;9(1):228-33. doi:10.32322/jhsm.1827790

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].

The Directories (indexes) and Platforms we are included in are at the bottom of the page.

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show







The indexes of the journal are ULAKBİM TR Dizin, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912

Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.